Study number 781667
Dates
Jun 16 2026-Oct 14 2026
Group
14
Location
Madison, Wisconsin
Age
18-55
Gender
Male OR Female
Smokers Allowed
No
Compensation
$12,041 to $13,189
Referral
$500
The investigational drug in this research study is being developed as a possible treatment for chronic immune-related inflammatory conditions, long-lasting, overactive immune system responses that cause inflammation though the body. To make it easier for patients to self-inject treatment, a new type of automatic injection device (autoinjector) has been developed.
Madison, WI is currently recruiting Healthy Adults, ages 18-55.
Refer a friend & receive $500 per qualified referral
Women Eligibility Criteria
Body Mass Index
Smoking criteria
Screening procedures
Call Now to Schedule Your Screening Appointment!
Check-in: June 16
Check-out: June 18
Follow up Visits:
Potential Follow-ups:
Sep 19 & 30, Oct 14
*Designs are selected after enrollment based on research needs.